Form 25-NSE Viking Therapeutics, Filed by: Nasdaq Stock Market LLC
X0203 0001354457 Nasdaq Stock Market LLC 0001607678 Viking Therapeutics, Inc. 001-37355 11119 North Torrey Pines Road, Suite 50 San Diego CA CALIFORNIA 92037 858-550-7810 Viking Therapeutics, Inc. Warrants expiring 04/13/2021 17 CFR 240.12d2-2(a)(2) Tara Petta Director 2021-04-08
form25
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Therapeutics (VKTX) Tops Q1 EPS by 2c
- Orion Group Interim Report January–March 2024
- Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!